TPSTNasdaq

Tempest Therapeutics, Inc.

Alert me on TPST

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Jun 24 Buy Angel Matthew Insider

1 week

−4.3%S&P +1.7%

1 month

−20.2%S&P +0.8%

3 months

−20.5%S&P +5.0%

6 months

Result in30 trading days

Mar 26 Buy Angel Matthew Insider

1 week

−4.2%S&P +1.7%

1 month

+3.6%S&P +10.9%

3 months

−34.9%S&P +13.3%

6 months

−50.1%S&P +20.2%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for TPST

17 held · newest 517 held · newest 2

Loading the filings.

See all 17 filings for TPST

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

Mar 30, 2026 Schedule 13D, amended

Versant Vantage II, L.P.: 1.1%, 162,972 shares

Mar 24, 2026 Schedule 13D, amended

Matthew Angel: 37.4%, 5,531,516 shares

Feb 3, 2026 Schedule 13D

Matthew Angel: 35.9%, 4,837,070 shares

Dec 31, 2025 Schedule 13G

SABBY MANAGEMENT, LLC: 9.9%, 492,223 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.